254 related articles for article (PubMed ID: 26639966)
1. Cerebrospinal Fluid Anti-Amyloid-β Autoantibodies and Amyloid PET in Cerebral Amyloid Angiopathy-Related Inflammation.
Carmona-Iragui M; Fernández-Arcos A; Alcolea D; Piazza F; Morenas-Rodriguez E; Antón-Aguirre S; Sala I; Clarimon J; Dols-Icardo O; Camacho V; Sampedro F; Munuera J; Nuñez-Marin F; Lleó A; Fortea J; Gómez-Ansón B; Blesa R
J Alzheimers Dis; 2016; 50(1):1-7. PubMed ID: 26639966
[TBL] [Abstract][Full Text] [Related]
2. Anti-amyloid β autoantibodies in cerebral amyloid angiopathy-related inflammation: implications for amyloid-modifying therapies.
Piazza F; Greenberg SM; Savoiardo M; Gardinetti M; Chiapparini L; Raicher I; Nitrini R; Sakaguchi H; Brioschi M; Billo G; Colombo A; Lanzani F; Piscosquito G; Carriero MR; Giaccone G; Tagliavini F; Ferrarese C; DiFrancesco JC
Ann Neurol; 2013 Apr; 73(4):449-58. PubMed ID: 23625526
[TBL] [Abstract][Full Text] [Related]
3. Cerebral Amyloid Angiopathy and Cerebral Amyloid Angiopathy-Related Inflammation: Comparison of Hemorrhagic and DWI MRI Features.
Renard D; Tatu L; Collombier L; Wacongne A; Ayrignac X; Charif M; Boukriche Y; Chiper L; Fourcade G; Azakri S; Gaillard N; Mercier E; Lehmann S; Thouvenot E
J Alzheimers Dis; 2018; 64(4):1113-1121. PubMed ID: 30010128
[TBL] [Abstract][Full Text] [Related]
4. Cerebrospinal Fluid, MRI, and Florbetaben-PET in Cerebral Amyloid Angiopathy-Related Inflammation.
Renard D; Collombier L; Demattei C; Wacongne A; Charif M; Ayrignac X; Azakri S; Gaillard N; Boudousq V; Lehmann S; Menjot de Champfleur N; Thouvenot E
J Alzheimers Dis; 2018; 61(3):1107-1117. PubMed ID: 29254099
[TBL] [Abstract][Full Text] [Related]
5. Cerebral Amyloid Angiopathy-Related Microbleeds and Cerebrospinal Fluid Biomarkers in Alzheimer's Disease.
Noguchi-Shinohara M; Komatsu J; Samuraki M; Matsunari I; Ikeda T; Sakai K; Hamaguchi T; Ono K; Nakamura H; Yamada M
J Alzheimers Dis; 2017; 55(3):905-913. PubMed ID: 27802236
[TBL] [Abstract][Full Text] [Related]
6. Clinic-Based Validation of Cerebrospinal Fluid Biomarkers with Florbetapir PET for Diagnosis of Dementia.
Álvarez I; Aguilar M; González JM; Ysamat M; Lorenzo-Bosquet C; Alonso A; Tartari JP; Romero S; Diez-Fairen M; Carcel M; Pujalte F; Pastor P
J Alzheimers Dis; 2018; 61(1):135-143. PubMed ID: 29154286
[TBL] [Abstract][Full Text] [Related]
7. Prodromal Alzheimer's disease presenting as cerebral amyloid angiopathy-related inflammation with spontaneous amyloid-related imaging abnormalities and high cerebrospinal fluid anti-Aβ autoantibodies.
Boncoraglio GB; Piazza F; Savoiardo M; Farina L; DiFrancesco JC; Prioni S; Tagliavini F; Parati EA; Giaccone G
J Alzheimers Dis; 2015; 45(2):363-7. PubMed ID: 25537009
[TBL] [Abstract][Full Text] [Related]
8. Alzheimer's Disease Normative Cerebrospinal Fluid Biomarkers Validated in PET Amyloid-β Characterized Subjects from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study.
Li QX; Villemagne VL; Doecke JD; Rembach A; Sarros S; Varghese S; McGlade A; Laughton KM; Pertile KK; Fowler CJ; Rumble RL; Trounson BO; Taddei K; Rainey-Smith SR; Laws SM; Robertson JS; Evered LA; Silbert B; Ellis KA; Rowe CC; Macaulay SL; Darby D; Martins RN; Ames D; Masters CL; Collins S;
J Alzheimers Dis; 2015; 48(1):175-87. PubMed ID: 26401938
[TBL] [Abstract][Full Text] [Related]
9. Cerebrospinal Fluid Alzheimer's Disease Biomarkers in Cerebral Amyloid Angiopathy-Related Inflammation.
Renard D; Wacongne A; Ayrignac X; Charif M; Fourcade G; Azakri S; Le Floch A; Bouly S; Marelli C; Arquizan C; Hirtz C; Gabelle A; Thouvenot E; Lehmann S
J Alzheimers Dis; 2016; 50(3):759-764. PubMed ID: 26757185
[TBL] [Abstract][Full Text] [Related]
10. Cerebrospinal Fluid Biomarkers in Cerebral Amyloid Angiopathy.
Banerjee G; Ambler G; Keshavan A; Paterson RW; Foiani MS; Toombs J; Heslegrave A; Dickson JC; Fraioli F; Groves AM; Lunn MP; Fox NC; Zetterberg H; Schott JM; Werring DJ
J Alzheimers Dis; 2020; 74(4):1189-1201. PubMed ID: 32176643
[TBL] [Abstract][Full Text] [Related]
11. Comparison of cerebrospinal fluid profiles in Alzheimer's disease with multiple cerebral microbleeds and cerebral amyloid angiopathy-related inflammation.
Kimura A; Takemura M; Saito K; Yoshikura N; Hayashi Y; Harada N; Nishida H; Nakajima H; Inuzuka T
J Neurol; 2017 Feb; 264(2):373-381. PubMed ID: 28000005
[TBL] [Abstract][Full Text] [Related]
12. Florbetapir Regional Distribution in Cerebral Amyloid Angiopathy and Alzheimer's Disease: A PET Study.
Planton M; Saint-Aubert L; Raposo N; Payoux P; Salabert AS; Albucher JF; Olivot JM; Péran P; Pariente J
J Alzheimers Dis; 2020; 73(4):1607-1614. PubMed ID: 31958082
[TBL] [Abstract][Full Text] [Related]
13. Florbetapir imaging in cerebral amyloid angiopathy-related hemorrhages.
Raposo N; Planton M; Péran P; Payoux P; Bonneville F; Lyoubi A; Albucher JF; Acket B; Salabert AS; Olivot JM; Hitzel A; Chollet F; Pariente J
Neurology; 2017 Aug; 89(7):697-704. PubMed ID: 28724587
[TBL] [Abstract][Full Text] [Related]
14. Core cerebrospinal fluid biomarker profile in cerebral amyloid angiopathy: A meta-analysis.
Charidimou A; Friedrich JO; Greenberg SM; Viswanathan A
Neurology; 2018 Feb; 90(9):e754-e762. PubMed ID: 29386280
[TBL] [Abstract][Full Text] [Related]
15. β-Amyloid in CSF: Biomarker for preclinical cerebral amyloid angiopathy.
van Etten ES; Verbeek MM; van der Grond J; Zielman R; van Rooden S; van Zwet EW; van Opstal AM; Haan J; Greenberg SM; van Buchem MA; Wermer MJ; Terwindt GM
Neurology; 2017 Jan; 88(2):169-176. PubMed ID: 27903811
[TBL] [Abstract][Full Text] [Related]
16. Anti-Aβ autoantibodies in the CSF of a patient with CAA-related inflammation: a case report.
DiFrancesco JC; Brioschi M; Brighina L; Ruffmann C; Saracchi E; Costantino G; Galimberti G; Conti E; Curtò NA; Marzorati L; Remida P; Tagliavini F; Savoiardo M; Ferrarese C
Neurology; 2011 Mar; 76(9):842-4. PubMed ID: 21357837
[No Abstract] [Full Text] [Related]
17. Cortical superficial siderosis: Prevalence and biomarker profile in a memory clinic population.
Shams S; Martola J; Charidimou A; Cavallin L; Granberg T; Shams M; Forslin Y; Aspelin P; Kristoffersen-Wiberg M; Wahlund LO
Neurology; 2016 Sep; 87(11):1110-7. PubMed ID: 27534713
[TBL] [Abstract][Full Text] [Related]
18. Cerebrospinal Fluid Biomarkers and Amyloid-β Elimination from the Brain in Cerebral Amyloid Angiopathy-Related Inflammation.
Sakai K; Noguchi-Shinohara M; Tanaka H; Ikeda T; Hamaguchi T; Kakita A; Yamada M; Ono K
J Alzheimers Dis; 2023; 91(3):1173-1183. PubMed ID: 36565118
[TBL] [Abstract][Full Text] [Related]
19. Cerebrospinal Fluid Profile of Tau, Phosphorylated Tau, Aβ42, and Aβ40 in Probable Cerebral Amyloid Angiopathy.
Grangeon L; Paquet C; Guey S; Zarea A; Martinaud O; Rotharmel M; Maltête D; Quillard-Muraine M; Nicolas G; Charbonnier C; Chabriat H; Wallon D
J Alzheimers Dis; 2022; 87(2):791-802. PubMed ID: 35367960
[TBL] [Abstract][Full Text] [Related]
20. Cerebrospinal Fluid Biomarkers in Dementia Patients with Cerebral Amyloid Angiopathy.
Li YF; Ge FF; Zhang Y; You H; Zhang ZX
Chin Med Sci J; 2015 Sep; 30(3):170-3. PubMed ID: 26564416
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
